Mon-Parin Injection

Mon-Parin Injection is an anticoagulant which prevents abnormal clotting of blood. It not only prevents the formation of harmful blood clots in the legs, lungs, and heart but also stops them from growing bigger.

Mon-Parin Injection is administered under the supervision of a doctor. Your doctor will decide how often you should take this medicine. This may change from time to time depending on how well it is working. You should take this medicine regularly to get the most benefit, even if you feel fine. It is preventing future harm. Your doctor may get regular blood tests done to make sure this medicine is working well and monitor the levels of potassium and platelets.

Use of this medicine may increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. You should be careful while shaving, cutting nails, using sharp objects, or engaging in contact sports.

Before you use this medicine, let your doctor know if you have any preexisting medical conditions. Let your doctor also know about all the medicines you are taking. In case of pregnancy, consult your doctor if it is safe to use this medicine.

• Prevention of Blood clots

Prevention of Blood clots
Formation of blood clots blocks one or more veins, usually in your legs. Mon-Parin Injection is used to prevent formation of blood clots near the surface of your skin. It dissolves the clots and also relieves pain and inflammation by increasing the blood flow. This improves the overall healing process.

Mon-Parin Injection is given as an injection by the doctor and should not be self- administered. The condition usually improves on its own in some time. Additionally, the doctor might recommend applying heat to the painful area, elevating the affected leg, using an over-the-counter painkiller and possibly wearing compression stockings.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Heprin

• Bleeding
• Erythema (skin redness)

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Mon-Parin Injection is an anticoagulant. It works by preventing the formation of harmful blood clots. Although it does not dissolve the existing blood clots, it prevents them from growing larger and causing blockages in the blood vessels.

• Notify your doctor if you see blood in your urine or stool or any unusual bleeding from your skin, gums or nose.
• Inform your doctor if you experience rash, itching, swelling of the face, tongue, and throat while you receive this medicine.

Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 853-59.

Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 591-93.

Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 367-73.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 652-53.

Heparin sodium. Hurley, Berkshire: Leo Laboratories Limited; 1975 [revised Sep. 2016]. [Accessed 18 Mar. 2019] (online) Available from:

Drugs.com. Heparin Pregnancy and Breastfeeding Warnings. [Accessed 18 Mar. 2019] (online) Available from:

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 18 Mar. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). Heparin. [Accessed 18 Mar. 2019] (online) Available from: